Filarial lymphedema (LE) remains a significant global problem despite the progress made
toward elimination of lymphatic filariasis (LF). In Ghana, the main approach to LF is …

Lymphatic filariasis, also known as elephantiasis, is a debilitating parasitic disease that has
been prevalent in various parts of the world, including China and Ghana. This paper …

Background Onchocerciasis causes chronic systemic inflammation. Several studies have
used markers such as haemato-biochemical indices to predict the occurrence of systemic …

Background The Global Programme to Eliminate Lymphatic Filariasis has made significant
gains through mass drug administration (MDA) of Ivermectin/Albendazole. Periodic …

Studies on the distribution of lymphatic filariasis (LF) have mostly focused on reporting
prevalence at the community level and distribution at the district levels. Understanding the …

Lymphatic filariasis (LF) is a mosquito-borne neglected tropical disease that is one of the
leading global causes of permanent disability. To date, LF interventions have been largely …

Globally, lymphatic filariasis poses a hazard to 859 million people in 50 nations. Because of
its severity, the majority of medications that are now on the market are microfilaricidal …

Chronic lymphedema caused by infection of Wuchereria bancrofti is a disfiguring disease
that leads to physical disability, stigmatization, and reduced quality of life. The edematous …

Brugian filariasis (BF) has reemerged in Sri Lanka recently. Studies suggest the emergence
of a variant brugian parasite. Knowledge on transmission dynamics is important in …

Filarial infections alter the immune environment through a variety of mechanisms including
shaping the T cell subset repertoire and by affecting the function of antigen presenting cells …